In this issue of the journal Pareek and colleagues provide a thorough, comprehensive review article on chlorthalidone (CTD). They report that in various global large trials like TOMHS, MRFIT, SHEP, ALLHAT, and SPRINT, CTD has reduced cardiovascular (CV) events, strokes, and, most importantly, mortality across various patient subgroups.
Keywords: Chlorthalidone, Hydrochlorothiazide, Thiazides.
How to cite this article: Messerli FH. The Chlorthalidone Saga: How the US Medical Community was mislead in Past? Hypertens J 2016;2(4):209-210.
Source of support: Nil
Conflict of interest: None